THY1 and cancer: The expression of cancer stem-like cell markers was investigated in the tumoroids since chemoresistance is often attributed to the presence of cancer stem-like cells.[94–98] Increases in stem markers CD44, CD24, and CD90 were observed with the addition of MSC and macrophages to the tri-component tumoroids.